Search for New Potential T-Cell and B-Cell Epitopes in the Spike Protein of SARS-CoV-2

Cover Page

Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription Access

Abstract

The current epidemiological situation, including the existence of new SARS-CoV-2 virus with a high mutagenicity, requires fundamentally new deadlines for the development of vaccines, which may be achieved only applying modern computing technologies and simulation. Epitopes have been found in the spike protein of the SARS-CoV-2 virus using immunoinformatics methods, and their allergenicity and immunogenecity was predicted. It is shown that a vaccine against SARS-CoV-2 can be designed based on these epitopes.

About the authors

I. A. Kolesnikov

National Research Centre “Kurchatov Institute”, 123182, Moscow, Russia

Email: a.1wanowskiy@gmail.com
Россия, Москва

V. I. Timofeev

National Research Centre “Kurchatov Institute”, 123182, Moscow, Russia; Shubnikov Institute of Crystallography, Federal Scientific Research Centre “Crystallography and Photonics,” Russian Academy of Sciences, 119333, Moscow, Russia

Email: a.1wanowskiy@gmail.com
Россия, Москва; Россия, Москва

M. V. Nikolenko

National Research Centre “Kurchatov Institute”, 123182, Moscow, Russia

Email: a.1wanowskiy@gmail.com
Россия, Москва

A. V. Ermakov

National Research Centre “Kurchatov Institute”, 123182, Moscow, Russia

Email: a.1wanowskiy@gmail.com
Россия, Москва

A. S. Ivanovsky

Shubnikov Institute of Crystallography, Federal Scientific Research Centre “Crystallography and Photonics,” Russian Academy of Sciences, 119333, Moscow, Russia

Email: a.1wanowskiy@gmail.com
Россия, Москва

Yu. A. Dyakova

National Research Centre “Kurchatov Institute”, 123182, Moscow, Russia

Email: a.1wanowskiy@gmail.com
Россия, Москва

Yu. V. Pisarevsky

Shubnikov Institute of Crystallography, Federal Scientific Research Centre “Crystallography and Photonics,” Russian Academy of Sciences, 119333, Moscow, Russia; National Research Centre “Kurchatov Institute”, 123182, Moscow, Russia

Email: a.1wanowskiy@gmail.com
Россия, Москва; Россия, Москва

M. V. Kovalchuk

National Research Centre “Kurchatov Institute”, 123182, Moscow, Russia; Shubnikov Institute of Crystallography, Federal Scientific Research Centre “Crystallography and Photonics,” Russian Academy of Sciences, 119333, Moscow, Russia

Author for correspondence.
Email: a.1wanowskiy@gmail.com
Россия, Москва; Россия, Москва

References

  1. Coronaviridae Study Group of the International Committee on Taxonomy of Viruses // Nat Microbiol. 2020. V. 5 (4). P. 536. https://doi.org/10.1038/s41564-020-0695-z
  2. Beeching N.J., Fletcher T.E., Flower R. // BMJ Best Practice Coronavirus Disease (COVID-19).
  3. Heymann D.L., Shido N. // Lancet. 2020. V. 395 (10224). P. 542. https://doi.org/10.1016/S0140-6736(20)30374-3
  4. Clinical management of severe acute respiratory infection when novel coronavirus (2019-nCoV) infection is suspected: interim guidance, WHO, 2020, 28 January.
  5. Araf Y., Moin A.T., Timofeev V.I. et al. // Front. Immunol. 2022. V. 13. 863234. https://doi.org/10.3389/fimmu.2022.863234
  6. Abass O.A., Timofeev V.I., Sarkar B. et al. // J. Biomolecular Structure and Dynamics. 2021. V. 40 (16). P. 7283. https://doi.org/10.1080/07391102.2021.1896387
  7. Quarleri J., Galvan V., Delpino M.V. // GeroScience. 2022. V. 44 (1). P. 53. https://doi.org/10.1007/s11357-021-00500-4
  8. Gowrisankar A., Priyanka T.M., Banerjee S. // Eur. Phys. J. Plus. 2022. V. 137. P. 100. https://doi.org/10.1140/epjp/s13360-021-02321-y
  9. Yao L., Zhu K. L., Jiang X. L. et al. // Lancet. Infectious Diseases. 2022. V. 22. № 8. P. 1116. https://doi.org/10.1016/S1473-3099(22)00410-8
  10. Cao Y., Yisimayi A., Jian F. et al. // Nature. 2022. V. 608 (7923). P. 593. https://doi.org/10.1038/s41586-022-04980-y
  11. Gallagher T.M., Buchmeier M.J. // Virology. 2001. V. 279. № 2. P. 371.
  12. Larsen M.V., Lundegaard C., Lamberth K. et al. // BMC Bioinformatics. 2007. V. 8. 424. https://doi.org/10.1186/1471-2105-8-424
  13. Buus S., Lauemoller S.L., Worning P. et al. // Tissue Antigens. 2003. V. 62. № 5. P. 378.
  14. Potocnakova L., Bhide M., Pulzova L.B. // J. Immunol. Res. 2016. 6760830. https://doi.org/10.1155/2016/6760830
  15. Ponomarenko J., Bui H.H., Li W. et al. // BMC Bioinformatics. 2008. V. 9. 514. https://doi.org/10.1186/1471-2105-9-514
  16. Dimitrov I., Bangov I., Flower D.R., Doytchinova I. // J. Mol. Model. 2014. V. 20. 2278. https://doi.org/10.1007/s00894-014-2278-5
  17. Gupta S., Kapoor P., Chaudhary K. et al. // PLoS ONE. 2013 V. 8 (9). № 73957. https://doi.org/10.1371/journal.pone.0073957
  18. Doytchinova I.A., Flower D.R. // BMC Bioinformatics. 2007. V. 8 (4). https://doi.org/10.1186/1471-2105-8-4
  19. Kudriavtsev A.V., Vakhrusheva A.V., Novoseletsky V.N. et al. // Viruses. 2022. V. 14 (8). 1603. https://doi.org/10.3390/v14081603
  20. Hallgren J., Konstantinos D.T., Pedersen M.D. et al. // bioRxiv. 2022. https://doi.org/10.1101/2022.04.08.487609
  21. Sharma N., Naorem L.D., Jain S., Raghava G.P.S. // Briefings in bioinformatics. 2022. V. 23. № 5. 174. https://doi.org/10.1093/bib/bbac174

Supplementary files

Supplementary Files
Action
1. JATS XML
2.

Download (473KB)
3.

Download (29KB)
4.

Download (541KB)
5.

Download (461KB)
6.

Download (393KB)

Copyright (c) 2023 Russian Academy of Sciences